Market Insights Health Medical Technology

Medical Devices - Singapore

Singapore

In Singapore, the revenue in the Medical Devices market market is estimated to reach US$1,119.00m in 2024.
The largest market within this market is Cardiology_Devices, which is projected to have a market volume of US$156.40m in the same year.
It is expected that the revenue will experience an annual growth rate of 8.99% from 2024 to 2029, resulting in a market volume of US$1,721.00m by 2029.
When compared globally, the United States is forecasted to generate the highest revenue in this market, with US$181.00bn in 2024.
Singapore is leading the way in the Medical Devices market with its innovative technologies and strong regulatory framework.

Key regions: Germany, Spain, Japan, United Kingdom, United States

Market

Region

Region comparison

Currency

Analyst Opinion

The Medical Devices market in Singapore is experiencing significant growth and development.

Customer preferences: Customers in Singapore have a strong preference for technologically advanced medical devices that offer high quality and reliable performance. They value devices that are user-friendly, efficient, and provide accurate results. Additionally, customers in Singapore prioritize safety and compliance with international standards when it comes to medical devices.

Trends in the market: One of the key trends in the Medical Devices market in Singapore is the increasing demand for wearable medical devices. These devices, such as fitness trackers and smartwatches with health monitoring capabilities, are gaining popularity among consumers who are becoming more health-conscious and proactive in monitoring their own health. This trend is driven by advancements in technology, which have made it possible to develop smaller, more portable, and user-friendly medical devices. Another trend in the market is the growing adoption of telemedicine and remote patient monitoring. With the advancement of digital technology, healthcare providers in Singapore are increasingly using telemedicine platforms and remote monitoring devices to provide healthcare services remotely. This trend is particularly relevant in the context of the COVID-19 pandemic, as it allows for the delivery of healthcare services without the need for physical contact.

Local special circumstances: Singapore is known for its strong healthcare infrastructure and high-quality healthcare services. The country has a well-established regulatory framework for medical devices, which ensures that only safe and effective devices are available in the market. This regulatory environment, coupled with the country's focus on research and development, has created a conducive environment for the growth of the Medical Devices market in Singapore.

Underlying macroeconomic factors: Singapore has a rapidly aging population, which is driving the demand for medical devices. As the population ages, there is an increased need for medical devices that can help manage chronic conditions and improve the quality of life for older adults. Additionally, Singapore has a high healthcare expenditure per capita, indicating a willingness to spend on healthcare products and services. Furthermore, Singapore is positioning itself as a hub for medical technology innovation and development. The government has implemented various initiatives to support the growth of the medical devices industry, including funding programs and tax incentives for research and development activities. These initiatives are attracting both local and international companies to invest in the Medical Devices market in Singapore, further driving its growth and development.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.